20
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found

      Elevated Pituitary LH and Depressed Pituitary Prolactin Levels in Female Hamsters with Pineal-Induced Gonadal Atrophy and the Effects of Chronic Treatment with Synthetic LRF

      research-article

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Light deprivation by blinding leads to involution of the reproductive organs and cessation of cyclic vaginal phenomena in adult fe-male hamsters. Associated with the atrophy of the reproductive system are elevated LH levels and depressed prolactin levels in the anterior pituitary gland. Chronic treatment (15 or 30 days) of blind hamsters with synthetic luteinizing hormone releasing factor (LRF) decreased pituitary levels and elevated plasma titers of LH. Neither pituitary nor plasma levels of prolactin were influenced by LRF treatment. Pinealectomy completely reversed the effects of blinding on the reproductive organs and on the pituitary levels of LH and prolactin.

          Related collections

          Author and article information

          Journal
          NEN
          Neuroendocrinology
          10.1159/issn.0028-3835
          Neuroendocrinology
          S. Karger AG
          0028-3835
          1423-0194
          1974
          1974
          20 March 2008
          : 14
          : 5
          : 310-320
          Affiliations
          Department of Anatomy, The University of Texas Health Science Center at San Antonio, San Antonio, Tex.
          Article
          122274 Neuroendocrinology 1974;14:310–320
          10.1159/000122274
          4603274
          542ccfcb-c742-446c-9cde-efff3b13a2cb
          © 1974 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          History
          : 10 September 1973
          : 07 November 1973
          Page count
          Pages: 11
          Categories
          Paper

          Endocrinology & Diabetes,Neurology,Nutrition & Dietetics,Sexual medicine,Internal medicine,Pharmacology & Pharmaceutical medicine
          Luteinizing hormone,Pineal gland,Blinding,Prolactin,Luteinizing hormone releasing factor,Ovary,Vaginal cycle,Hamster

          Comments

          Comment on this article